United for Schizophrenia: Unbranded Site for HCPs from Alkermes
Website Features
Nuplazid Email: “What to expect from NUPLAZID® (pimavanserin)”
Received: Apr 3, 2019 at 3:30 AM Subject: What to expect from NUPLAZID® (pimavanserin) From: ACADIA Pharmaceuticals Inc.
Nuplazid Email: “Finding hope through the experience of others”
Received: Apr 2, 2019 at 5:19 PM Subject: Finding hope through the experience of others From: ACADIA Pharmaceuticals Inc.
Nuplazid Email: “Helping you identify your symptoms”
Received: Mar 26, 2019 at 5:30 PM Subject: Helping you identify your symptoms From: ACADIA Pharmaceuticals Inc.
National Psoriasis Foundation Email for Ilumya: “Get your plaque psoriasis questions answered! – Partner Message”
Received: Mar 15, 2019 at 7:00 PM Subject: Get your plaque psoriasis questions answered! – Partner Message From: National Psoriasis Foundation
Orilissa Email: “Are these superfoods a part of your diet?”
Received: Mar 20, 2019 at 9:45 AM Subject: Are these superfoods a part of your diet? From: Endo Info
Afstyla Email: “Consider a twice-weekly therapy that keeps things simple for you”
Received: Feb 20, 2018 at 7:15 PM Subject: Consider a twice-weekly therapy that keeps things simple for you From: CSL Behring Team
“Is this email relevant to you” Question + Survey (Afstyla)
Novoeight HCP Email: “See a Comparison Chart”
Received: Oct 4, 2018 at 12:01 PM Subject: 1 alternative to Helixate® FS: Novoeight® (Antihemophilic Factor [Recombinant]). From: Novo Nordisk
Patient Email from Nuplazid: “You signed up to learn more. We’re happy to help”
From: ACADIA Pharmaceuticals Inc. Sent on: Jan 21, 2019 Subject line: You signed up to learn more. We’re happy to help Preheader: Please see Important Safety Information including Boxed WARNING at the bottom of this email.